Notch signalling cascade and proinflammatory mediators in peri-implant lesions with different RANKL/OPG ratios-An observational study.
Notch signaling
gene expression
peri-implant mucositis
peri-implantitis
Journal
Journal of periodontal research
ISSN: 1600-0765
Titre abrégé: J Periodontal Res
Pays: United States
ID NLM: 0055107
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
revised:
24
10
2022
received:
18
07
2022
accepted:
29
12
2022
pubmed:
9
1
2023
medline:
21
3
2023
entrez:
8
1
2023
Statut:
ppublish
Résumé
Notch signaling pathway has been linked to bone loss in periodontitis and peri-implantitis. This research aimed to determine the Notch signaling molecules expression levels (Notch1, Notch2, Jagged1, Hes1, and Hey1), along with bone remodeling mediators (RANKL and OPG) and proinflammatory cytokines (TNF-α, IL-17, IL-1β, and IL-6) in patients with peri-implant diseases. The aforementioned markers' expression was evaluated in patients with different RANKL/OPG ratios. Fifty patients with peri-implantitis (PI group) and 45 patients with peri-implant mucositis (PM group) were enrolled. Relative gene expression levels of investigated molecules were determined by reverse transcriptase-real-time polymerase chain reaction. On the basis of RANKL/OPG ratio, all peri-implant lesions were divided into subgroups: RANKL-predominant (RANKL > OPG) and OPG-predominant (RANKL < OPG). Clinical periodontal parameters (probing depth-PD, bleeding on probing-BOP, clinical attachment level-CAL and plaque index-PLI), were recorded for each patient around every tooth, and around placed implants (PDi, BOPi, CALi, PLIi). RANKL-predominant PM patients exhibited higher expression levels of Notch2 (p = .044) and Hey1 (p = .005) compared to OPG-predominant lesions. In all RANKL-predominant cases, Hey1 (p = .001), IL-1β (p = .005), IL-6 (p = .002) were overexpressed in PI comparing to PM, accompanied with significantly higher PDi, CALi and PLIi in PI than PM (p = .001, p = .001 and p = .009). Notch2 upregulation in RANKL-predominant PM lesions could be an important contributor to alveolar bone resorption and represent a predictor of PM to PI transition. Similarly, the overexpression of IL-1β and IL-6 might provide an osteoclastogenic environment in PI RANKL-predominant lesions.
Sections du résumé
BACKGROUND & OBJECTIVE
OBJECTIVE
Notch signaling pathway has been linked to bone loss in periodontitis and peri-implantitis. This research aimed to determine the Notch signaling molecules expression levels (Notch1, Notch2, Jagged1, Hes1, and Hey1), along with bone remodeling mediators (RANKL and OPG) and proinflammatory cytokines (TNF-α, IL-17, IL-1β, and IL-6) in patients with peri-implant diseases. The aforementioned markers' expression was evaluated in patients with different RANKL/OPG ratios.
METHODS
METHODS
Fifty patients with peri-implantitis (PI group) and 45 patients with peri-implant mucositis (PM group) were enrolled. Relative gene expression levels of investigated molecules were determined by reverse transcriptase-real-time polymerase chain reaction. On the basis of RANKL/OPG ratio, all peri-implant lesions were divided into subgroups: RANKL-predominant (RANKL > OPG) and OPG-predominant (RANKL < OPG). Clinical periodontal parameters (probing depth-PD, bleeding on probing-BOP, clinical attachment level-CAL and plaque index-PLI), were recorded for each patient around every tooth, and around placed implants (PDi, BOPi, CALi, PLIi).
RESULTS
RESULTS
RANKL-predominant PM patients exhibited higher expression levels of Notch2 (p = .044) and Hey1 (p = .005) compared to OPG-predominant lesions. In all RANKL-predominant cases, Hey1 (p = .001), IL-1β (p = .005), IL-6 (p = .002) were overexpressed in PI comparing to PM, accompanied with significantly higher PDi, CALi and PLIi in PI than PM (p = .001, p = .001 and p = .009).
CONCLUSIONS
CONCLUSIONS
Notch2 upregulation in RANKL-predominant PM lesions could be an important contributor to alveolar bone resorption and represent a predictor of PM to PI transition. Similarly, the overexpression of IL-1β and IL-6 might provide an osteoclastogenic environment in PI RANKL-predominant lesions.
Substances chimiques
Cytokines
0
Dental Implants
0
Interleukin-6
0
Receptors, Notch
0
RANK Ligand
0
TNFRSF11B protein, human
0
Osteoprotegerin
0
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
360-368Subventions
Organisme : Ministry of Education, Science and Technological Development of Republic of Serbia
ID : 451-03-68/2022-14/200129
Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol. 2015;42(Suppl 16):S158-S171.
Schwarz F, Derks J, Monje A, Wang HL. Peri-implantitis. J Periodontol. 2018;89:S267-S290. doi:10.1002/jper.16-0350
Heitz-Mayfield LJA, Salvi GE. Peri-implant mucositis. J Clin Periodontol. 2018;45:S237-S245.
Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010;8(7):481-490. doi:10.1038/nrmicro2337
Heitz-Mayfield L, Lang NP. Comparative biology of chronic and aggressive periodontitis vs. peri-implantitis. Periodontol 2000. 2000;2010(53):167-181.
Salvi GE, Lang NP. Diagnostic parameters for monitoring peri-implant conditions. Int J Oral Maxillofac Implants. 2004;19(7):116-127.
Tompkins KA. The osteoimmunology of alveolar bone loss. Connect Tissue Res. 2016;57(2):69-90.
Taubman MA, Valverde P, Han XZ, Kawai T. Immune response: the key to bone resorption in periodontal disease. J Periodontol. 2005;76(11):2033-2041.
Choi Y, Woo KM, Ko SH, et al. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8+ T cells. Eur J Immunol. 2001;31(7):2179-2188.
Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology. J Clin Periodontol. 2012;39(3):239-248.
Bostanci N, Ilgenli T, Emingil G, et al. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio. J Clin Periodontol. 2007;34(5):370-376.
Liu Y, Liu Q, Li Z, et al. Long non-coding RNA and mRNA expression profiles in peri-implantitis vs periodontitis. J Periodontal Res. 2020;55(3):342-353.
Milinkovic I, Djinic Krasavcevic A, Nikolic N, et al. Notch down-regulation and inflammatory cytokines and RANKL overexpression involvement in peri-implant mucositis and peri-implantitis: a cross-sectional study. Clin Oral Implants Res. 2021;32(12):1496-1505.
Rakic M, Lekovic V, Nikolic-Jakoba N, Vojvodic D, Petkovic-Curcin A, Sanz M. Bone loss biomarkers associated with peri-implantitis. A cross-sectional study. Clin Oral Implants Res. 2013;24(10):1110-1116.
Duarte PM, Serrao CR, Miranda TS, et al. Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with peri-implantitis? A systematic review. J Periodontal Res. 2016;51(6):689-698.
Theodoridis C, Doulkeridou C, Menexes G, Vouros I. Comparison of RANKL and OPG levels in peri-implant crevicular fluid between healthy and diseased peri-implant tissues. A systematic review and meta-analysis. Clin Oral Investig. 2022;26(1):823-836.
Canalis E. Notch in skeletal physiology and disease. Osteoporos Int. 2018;29(12):2611-2621.
Kopan R, Ilagan MXG. The canonical notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216-233.
Zanotti S, Canalis E. Notch signaling and the skeleton. Endocr Rev. 2016;37(3):223-253.
Zhao BH. TNF and bone remodeling. Curr Osteoporos Rep. 2017;15(3):126-134.
Berglundh T, Armitage G, Araujo MG, et al. Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89:S313-S318.
Aloufi F, Bissada N, Ficara A, Faddoul F, Al-Zahrani MS. Clinical assessment of peri-implant tissues in patients with varying severity of chronic periodontitis. Clin Implant Dent Relat Res. 2009;11(1):37-40.
Polson AM. The research team, calibration, and quality assurance in clinical trials in periodontics. Ann Periodontol. 1997;2(1):75-82.
Dutzan N, Vernal R, Hernandez M, et al. Levels of interferon-gamma and transcription factor T-bet in progressive periodontal lesions in patients with chronic periodontitis. J Periodontol. 2009;80(2):290-296.
Mijailovic I, Nikolic N, Djinic A, et al. The down-regulation of notch 1 signaling contributes to the severity of bone loss in aggressive periodontitis. J Periodontol. 2020;91(4):554-561.
Bostanci N, Belibasakis GN. Gingival crevicular fluid and its immune mediators in the proteomic era. Periodontol 2000. 2018;76(1):68-84.
Nikolic N, Jakovljevic A, Carkic J, et al. Notch signaling pathway in apical periodontitis: correlation with bone resorption regulators and proinflammatory cytokines. J Endod. 2019;45(2):123-128.
Djinic Krasavcevic A, Nikolic N, Mijailovic I, et al. Impact of notch signalling molecules and bone resorption regulators on clinical parameters in periodontitis. J Periodontal Res. 2021;56(1):131-138.
Savage A, Eaton KA, Moles DR, Needleman I. A systematic review of definitions of periodontitis and methods that have been used to identify this disease. J Clin Periodontol. 2009;36(6):458-467.
Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89:S173-S182.
Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25(4):229-235.
Sanz M, Chapple IL. Clinical research on peri-implant diseases: consensus report of working group 4. J Clin Periodontol. 2012;39(Suppl 12):202-206.
Ramanauskaite A, Becker K, Schwarz F. Clinical characteristics of peri-implant mucositis and peri-implantitis. Clin Oral Implants Res. 2018;29(6):551-556.
Monje A, Amerio E, Farina R, et al. Significance of probing for monitoring peri-implant diseases. Int J Oral Implantol. 2021;14:385-399.
Ata-Ali J, Flichy-Fernandez AJ, Ata-Ali F, Penarrocha-Diago M. Clinical, microbiologic, and host response characteristics in patients with peri-implant mucositis. Int J Oral Maxillofac Implants. 2013;28(3):883-890.
Severino VO, Beghini M, de Araújo MF, et al. Expression of IL-6, IL-10, IL-17 and IL-33 in the peri-implant crevicular fluid of patients with peri-implant mucositis and peri-implantitis. Arch Oral Biol. 2016;72:194-199.
Dinarello CA. Proinflammatory cytokines. Chest. 2000;118(2):503-508.
Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12):2673-2682.
Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol. 2006;6(4):329-334.
Tanaka K, Hashizume M, Mihara M, Yoshida H, Suzuki M, Matsumoto Y. Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model. Clin Exp Immunol. 2014;175(2):172-180.
Konttinen YT, Ma J, Lappalainen R, et al. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent. 2006;26(2):135-141.
Severino VO, Napimoga MH, de Lima Pereira SA. Expression of IL-6, IL-10, IL-17 and IL-8 in the peri-implant crevicular fluid of patients with peri-implantitis. Arch Oral Biol. 2011;56(8):823-828.
Maier MM, Gessler M. Comparative analysis of the human and mouse Hey1 promoter: hey genes are new notch target genes. Biochem Biophys Res Commun. 2000;275(2):652-660. doi:10.1006/bbrc.2000.3354
Duan L, Ren YJ. Role of notch signaling in osteoimmunology-from the standpoint of osteoclast differentiation. Eur J Orthod. 2013;35(2):175-182. doi:10.1093/ejo/cjs002
Regan J, Long FX. Notch signaling and bone remodeling. Curr Osteoporos Rep. 2013;11(2):126-129.